Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany

<div>Changes in BCVA from baseline in ETDRS letters for patients receiving ≤4 OCT examinations or ≥8 OCT examinations. BCVA: best-corrected visual acuity; ETDRS: Early Treatment for Diabetic Retinopathy Study; OCT: optical coherence tomography.</div>

Journal of Ophthalmology

fig4

Figure 4

Figure 4: Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany 

Figure 4 | Use of Imaging Modalities in Real Life: Impact on Visual Acuity Outcomes of Ranibizumab Treatment for Neovascular Age-Related Macular Degeneration in Germany 